当前位置: 首页 >> 检索结果
共有 4076 条符合本次的查询结果, 用时 1.1937548 秒

3521. Boarding the train.

来源: Lancet. 1990年336卷8717期720-1页

3522. ACE inhibitors and tissue binding.

来源: Lancet. 1990年336卷8717期718-20页

3523. Recurrent miscarriage.

作者: G M Stirrat.
来源: Lancet. 1990年336卷8716期673-5页
On epidemiological evidence, the definition of recurrent miscarriage should be three or more consecutive pregnancy losses. Data should be collected to 28 weeks' gestation but analysis up to 20-22 weeks' or 500 g fetal weight should also be possible. General practitioners and gynaecologists should do what they feel is suitable for couples whose history does not meet these criteria but a diagnosis of recurrent miscarriage should not be made. Women meeting the definition can be subdivided into primary and secondary groups, respectively consisting of those who have lost all previous pregnancies and those who have had one successful pregnancy followed by consecutive losses.

3524. Failure to thrive revisited.

来源: Lancet. 1990年336卷8716期662-3页

3525. Management of prolactinoma.

来源: Lancet. 1990年336卷8716期661页

3526. Nothing is unthinkable.

来源: Lancet. 1990年336卷8716期659-61页

3527. Treatment of epilepsy and febrile convulsions in children.

作者: G W Rylance.
来源: Lancet. 1990年336卷8713期488-91页

3528. Childhood epileptic syndromes.

作者: S J Wallace.
来源: Lancet. 1990年336卷8713期486-8页

3529. Bismuth and dyspepsia.

来源: Lancet. 1990年336卷8713期472-3页

3530. Consensus on IVIG.

来源: Lancet. 1990年336卷8713期470-2页

3531. Thin-membrane nephropathy--how thin is thin?

来源: Lancet. 1990年336卷8713期469-70页

3532. New and potential anticonvulsants.

作者: M J Brodie.;R J Porter.
来源: Lancet. 1990年336卷8712期425-6页

3533. Hantavirus disease.

来源: Lancet. 1990年336卷8712期407-8页

3534. What is known about the prevention of congenital toxoplasmosis?

作者: D Jeannel.;D Costagliola.;G Niel.;B Hubert.;M Danis.
来源: Lancet. 1990年336卷8711期359-61页
The French programme for the prevention of congenital toxoplasmosis consists of the diagnosis and treatment with spiramycin of acute infections during pregnancy and monthly follow-up of all identified seronegative women. The major flaw is that the efficacy of spiramycin in preventing contamination of the fetus, or at least in reducing the extent of the infection, has never been evaluated in a randomised placebo-controlled clinical trial. Its evaluation would require the follow-up of children born to mothers contaminated during pregnancy for more than 6 months, a goal that is difficult to obtain in current practice. The cost of the programme depends largely on the proportion of non-immune women of childbearing age. Since the modes of contamination are known and are linked to living habits, it should be possible to reduce the risk of infection during pregnancy by adequate health education. This approach is still to be evaluated.

3535. Established anticonvulsants and treatment of refractory epilepsy.

作者: M J Brodie.
来源: Lancet. 1990年336卷8711期350-4页

3536. Antenatal screening for toxoplasmosis in the UK.

来源: Lancet. 1990年336卷8711期346-8页

3537. Epilepsy in old age.

作者: R Tallis.
来源: Lancet. 1990年336卷8710期295-6页

3538. Diagnosis of epilepsy.

作者: D Chadwick.
来源: Lancet. 1990年336卷8710期291-5页

3539. Reflux and respiratory symptoms.

来源: Lancet. 1990年336卷8710期282-3页

3540. Quinolones in acute non-travellers' diarrhoea.

来源: Lancet. 1990年336卷8710期282页
共有 4076 条符合本次的查询结果, 用时 1.1937548 秒